ReP USP - Resultado da busca

Artigo de periodico
Endostatin gene therapy stimulates upregulation of ICAM-1 and VCAM-1 in a metastatic renal cell carcinoma model (2012)
Chaves, K. C. B.; Peron, Jean Pierre Schatzmann ; Chammas, R.; Turaça, L. T.; Pesquero, J. B.; Braga, M. S.; Foguer, K.; Schor, N.; Bellini, M. H.
Source: Cancer Gene Therapy. Unidade: FM
Subjects: IMUNOTERAPIA, DNA, CARCINOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAVES, K. C. B. et al. Endostatin gene therapy stimulates upregulation of ICAM-1 and VCAM-1 in a metastatic renal cell carcinoma model. Cancer Gene Therapy, v. 19, n. 8, p. 558-565, 2012Tradução . . Disponível em: https://doi.org/10.1038/cgt.2012.32. Acesso em: 19 ago. 2024.
APA
Chaves, K. C. B., Peron, J. P. S., Chammas, R., Turaça, L. T., Pesquero, J. B., Braga, M. S., et al. (2012). Endostatin gene therapy stimulates upregulation of ICAM-1 and VCAM-1 in a metastatic renal cell carcinoma model. Cancer Gene Therapy, 19( 8), 558-565. doi:10.1038/cgt.2012.32
NLM
Chaves KCB, Peron JPS, Chammas R, Turaça LT, Pesquero JB, Braga MS, Foguer K, Schor N, Bellini MH. Endostatin gene therapy stimulates upregulation of ICAM-1 and VCAM-1 in a metastatic renal cell carcinoma model [Internet]. Cancer Gene Therapy. 2012 ; 19( 8): 558-565.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1038/cgt.2012.32
Vancouver
Chaves KCB, Peron JPS, Chammas R, Turaça LT, Pesquero JB, Braga MS, Foguer K, Schor N, Bellini MH. Endostatin gene therapy stimulates upregulation of ICAM-1 and VCAM-1 in a metastatic renal cell carcinoma model [Internet]. Cancer Gene Therapy. 2012 ; 19( 8): 558-565.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1038/cgt.2012.32
Artigo de periodico
Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck (2008)
Michaluart, P.; Abdallah, K. A.; Lima, F. D.; Smith, R.; Moysés, R. A.; Coelho, V.; Victora, G. D.; Socorro-Silva, A.; Volsi, E. C.; Zárate-Bladés, C. R.; Ferraz, Alberto Rossetti; Barreto, A. K.; Chammas, M. C.; Gomes, R.; Gebrim, E.; Arakawa-Sugueno, L.; Fernandes, K. P.; Lotufo, Paulo Andrade; Cardoso, M. R.; Kalil, J.; Silva, Célio Lopes
Source: Cancer Gene Therapy. Unidades: HU, FMRP, FSP
Subjects: IMUNOTERAPIA, DNA, CARCINOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MICHALUART, P. et al. Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck. Cancer Gene Therapy, v. 15, n. 10, p. 676-684, 2008Tradução . . Disponível em: https://doi.org/10.1038/cgt.2008.35. Acesso em: 19 ago. 2024.
APA
Michaluart, P., Abdallah, K. A., Lima, F. D., Smith, R., Moysés, R. A., Coelho, V., et al. (2008). Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck. Cancer Gene Therapy, 15( 10), 676-684. doi:10.1038/cgt.2008.35
NLM
Michaluart P, Abdallah KA, Lima FD, Smith R, Moysés RA, Coelho V, Victora GD, Socorro-Silva A, Volsi EC, Zárate-Bladés CR, Ferraz AR, Barreto AK, Chammas MC, Gomes R, Gebrim E, Arakawa-Sugueno L, Fernandes KP, Lotufo PA, Cardoso MR, Kalil J, Silva CL. Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck [Internet]. Cancer Gene Therapy. 2008 ; 15( 10): 676-684.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1038/cgt.2008.35
Vancouver
Michaluart P, Abdallah KA, Lima FD, Smith R, Moysés RA, Coelho V, Victora GD, Socorro-Silva A, Volsi EC, Zárate-Bladés CR, Ferraz AR, Barreto AK, Chammas MC, Gomes R, Gebrim E, Arakawa-Sugueno L, Fernandes KP, Lotufo PA, Cardoso MR, Kalil J, Silva CL. Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck [Internet]. Cancer Gene Therapy. 2008 ; 15( 10): 676-684.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1038/cgt.2008.35
Artigo de periodico
A novel gene transfer strategy that combines promoter and transgene activities for improved tumor cell inhibition (2005)
Strauss, Bryan Eric; Bajgelman, Márcio Chaim; Costanzi-Strauss, Eugenia
Source: Cancer Gene Therapy. Unidade: ICB
Assunto: HISTOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
STRAUSS, Bryan Eric e BAJGELMAN, Márcio Chaim e COSTANZI-STRAUSS, Eugenia. A novel gene transfer strategy that combines promoter and transgene activities for improved tumor cell inhibition. Cancer Gene Therapy, v. 12, p. 935-946, 2005Tradução . . Disponível em: https://doi.org/10.1038/sj.cgt.7700846. Acesso em: 19 ago. 2024.
APA
Strauss, B. E., Bajgelman, M. C., & Costanzi-Strauss, E. (2005). A novel gene transfer strategy that combines promoter and transgene activities for improved tumor cell inhibition. Cancer Gene Therapy, 12, 935-946. doi:10.1038/sj.cgt.7700846
NLM
Strauss BE, Bajgelman MC, Costanzi-Strauss E. A novel gene transfer strategy that combines promoter and transgene activities for improved tumor cell inhibition [Internet]. Cancer Gene Therapy. 2005 ; 12 935-946.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1038/sj.cgt.7700846
Vancouver
Strauss BE, Bajgelman MC, Costanzi-Strauss E. A novel gene transfer strategy that combines promoter and transgene activities for improved tumor cell inhibition [Internet]. Cancer Gene Therapy. 2005 ; 12 935-946.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1038/sj.cgt.7700846

USP Schools

ReP

Filtros

Authors

Indexado em